Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:00 PM
Ignite Modification Date:
2025-12-24 @ 8:00 PM
NCT ID:
NCT05532904
Eligibility Criteria:
Inclusion Criteria:
* Having had an initial episode of symptomatic COVID-19 according to one of the following criteria:
* SARS-Cov-2 PCR +
* SARS-Cov-2 + antigenic test
* SARS-Cov-2 + serology
* Prolonged anosmia/ageusia of sudden onset
* Typical chest CT scan
* Still having at least one of the initial symptoms and possibly new symptoms including fatigue, dyspnea, cognitive impairment or pain beyond 4 weeks after the onset of the acute phase of the disease.
* These initial and persistent symptoms are not better explained by another diagnosis not known to be related to Covid-19.
* These symptoms are the cause of an alteration in quality of life and global functioning deemed significant by the patient.
* Having an indication to either supervised exercise and / or cognitive behavior therapy and / or cognitive remediation Exclusion Criteria
* Medical emergency requiring management not compatible with research
* Neuropsychiatric disorder likely to alter cognitive functions, prior to the Covid-19 episode
* Medical contraindication to exercise training such as pericarditis or progressive myocarditis
* Patient under state medical assistance
* Patient who does not speak French
* Pregnancy in progress
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05532904
Study Brief:
Protocol Section:
NCT05532904